JPMorgan Strengthens Position in 10x Genomics Amid Life Sciences Recovery
JPMorgan Chase & Co. has disclosed a $12.55 million stake in 10x Genomics, signaling institutional confidence in the spatial biology leader. This move comes as the life sciences tools sector navigates a transition toward high-resolution genomic mapping and single-cell analysis.